NEWS

Better indicators for blood loss. Age and preoperative PSA may not accurately indicate a patient's estimated blood loss (EBL) during radical prostatectomy. Read how using BMI and prostate size could provide a more accurate prediction.

Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.

Nature Publishing Group and AstraZeneca are pleased to congratulate the 2008 AstraZeneca Scholarship award recipients, Young et al., for their winning paper entitled "Combining gene and immunotherapy for prostate cancer." The award is bestowed on the most significant original research paper published in 2008.

Submit your paper to Nature Precedings while your manuscript is under consideration. This archive provides a rapid way to disseminate emerging results and new theories, solicit opinions, and record the provenance of ideas. Register to submit documents now.